MedPath

A multicenter observational study for measurement of SNPs in participants of the Japan Polyp Study Cohort

Not Applicable
Conditions
Colorectal cancer
Registration Number
JPRN-UMIN000049978
Lead Sponsor
ational Cancer Center Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
1230
Inclusion Criteria

Not provided

Exclusion Criteria

non

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Interaction between SNPs of ALDH2 and the effectiveness of aspirin in preventing the development of index lesions (ILs: cancers, adenomas with high-grade dysplasia, and adenomas measuring >= 10 mm) at 4 years
Secondary Outcome Measures
NameTimeMethod
1) Interaction between SNPs of ADH1B and the effectiveness of aspirin in preventing the development of ILs at 4 years 2) Interaction between SNPs of CYP2A6 and the effectiveness of aspirin in preventing the development of ILs at 4 years 3) Impacts of SNPs of ALDH2, ADH1B, and CYP2A6 on the development of ILs and adenomas within the JPS Cohort 4) Interaction between SNPs of ALDH2 and the effectiveness of aspirin in preventing the development of adenomas at 4 years 5) Interaction between SNPs of ADH1B and the effectiveness of aspirin in preventing the development of adenomas at 4 years 6) Interaction between SNPs of CYP2A6 and the effectiveness of aspirin in preventing the development of adenomas at 4 years 7) Analyses of 1) to 6) taking into account the age, sex, alcohol intake, smoking, height, and body weight 8) Analyses of 1) to 6) using the site, size, and morphology of colorectal cancer as endpoints
© Copyright 2025. All Rights Reserved by MedPath